Lidocaine

Written for veterinarians and veterinary nurses.Are you a pet owner? The owner guides are here.

This page reprints a manufacturer label. Everything below in quotation marks is copied from Lidocaine Hydrochloride Injectable-2%, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.

This page reprints the FDA label for Lidocaine Hydrochloride Injectable-2% by Clipper Distributing Company, LLC, a lidocaine product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 6 other stored labels carry the same active ingredient and are listed at the end.

The label

Product: Lidocaine Hydrochloride Injectable-2%. Manufacturer: Clipper Distributing Company, LLC. FDA Structured Product Label set id 97e3c22e-3bc8-42b2-9214-05228f407be9. Label effective 2013-06-17. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.

Indications

Lidocaine is a potent local anesthetic for producing epidural and nerve conduction anesthesia.

Dosage and Administration

Epidural Cattle and Horses - 5 to 15 mL Dogs and Cats - 1 mL per 10 pounds of body weight. Nerve Block Cattle and Horses - 5 to 20 mL Infiltration Dilute to 0.5% concentration (1 mL of 2% solution diluted with 3 mL of sterile water = 4 mL of a 0.5% solution) COMPOSITION Each mL of sterile aqueous solution contains: Lidocaine Hydrochloride........................2.0% Propylene Glycol..................................5.2% Sodium Chloride...................................0.5% Sodium Lactate....................................0.5% with Methylparaben 0.15%, Sodium Metabisulfite 0.10%, Propylparaben 0.03%, and Disodium Edetate 0.001% as preservatives. Store at controlled room temperature between 15 o and 30 o C (59 o -86 o F) TAKE TIME OBSERVE LABEL DIRECTIONS Lidocaine Inj-13 Label

Contraindications

Lidocaine is contraindicated in animals with a known hypersensitivity to the drug.

Precautions

Lidocaine is usually well tolerated. Nevertheless, as with all local anesthetics, untoward effects may occur due to hypersensitivity, faulty technique, overdosage and inadvertent intravascular or subarachnoid injection. In case of respiratory arrest, immediate resuscitation with oxygen is indicated.

Other labels for this ingredient

These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.

FDA adverse event reports

The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming lidocaine as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.

These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.

Dogs: 318 reports

Reactions most often coded in dogs, 318 reports
VeDDRA reaction termReports
Vomiting65
Other abnormal test result NOS59
Death48
Lethargy (see also Central nervous system depression in 'Neurological')45
Death by euthanasia41
Anorexia38
Diarrhoea36
Tachycardia32
Decreased appetite28
Elevated alanine aminotransferase (ALT)27
Cardiac arrest26
Pale mucous membrane26
Lack of efficacy - NOS25
Bradycardia22
Lethargy (see also Central nervous system depression in Neurological)22

Outcome as recorded by the reporter: Recovered/Normal 96; Ongoing 79; Died 53; Outcome Unknown 49; Euthanized 38; Recovered with Sequela 2.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Cats: 176 reports

Reactions most often coded in cats, 176 reports
VeDDRA reaction termReports
Behavioural disorder NOS27
Death23
Not eating22
Hyperthermia17
Lethargy (see also Central nervous system depression in 'Neurological')17
Other abnormal test result NOS15
Anorexia14
Dilated pupils14
Dysphoria14
Agitation13
Weight loss13
Death by euthanasia12
Hyperactivity11
Ataxia10
Dehydration10

Outcome as recorded by the reporter: Ongoing 58; Recovered/Normal 51; Outcome Unknown 31; Died 25; Euthanized 11; Recovered with Sequela 1.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Sources

Related

From Glarda

The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.

Glarda for practices